Skip to content

Clinical trials

Phase 2 Diabetes Mellitus, Type 1 trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Phase: Phase 2 Country / region: Sweden Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20082
20091
20111
20131
20141
20155
20162
20172
20182
20201
20211
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated5
Active, not recruiting3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Diamyd Medical AB2
Johnny Ludvigsson2
Lund University2
Novo Nordisk A/S2
University of Oulu2
Assistance Publique - Hôpitaux de Paris1
Creative Peptides Sweden Inc.1
Diamyd Therapeutics AB1
Göteborg University1
ITB-Med LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 125
Diabetes Mellitus8
Metabolic Diseases5
Autoimmune Diseases4
Glucose Metabolism Disorders4
Endocrine System Diseases2
Immune System Diseases2
Prediabetic State2
Diabetes Mellitus, Type 21
Diabetic Neuropathies1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.